These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 11267178)
1. Sirolimus rescue therapy for refractory rejection in renal transplant recipients. Hong JC; Kahan BD Transplant Proc; 2001; 33(1-2):1033. PubMed ID: 11267178 [No Abstract] [Full Text] [Related]
2. Sirolimus rescue therapy for refractory rejection in renal transplantation. Hong JC; Kahan BD Transplantation; 2001 Jun; 71(11):1579-84. PubMed ID: 11435968 [TBL] [Abstract][Full Text] [Related]
3. Cyclosporine elimination in the presence of TOR inhibitors: effects on renal function, acute rejection, and safety. Velosa JA; Larson TS; Gloor JM; Stegall MD Am J Kidney Dis; 2001 Oct; 38(4 Suppl 2):S3-S10. PubMed ID: 11583938 [TBL] [Abstract][Full Text] [Related]
4. Randomized trial of three different immunosuppressive regimens to prevent chronic renal allograft rejection. Burke GW; Ciancio C; Blomberg BB; Rosen A; Suzart K; Roth D; Kupin W; Esquenazi V; Miller J Transplant Proc; 2002 Aug; 34(5):1610-1. PubMed ID: 12176505 [No Abstract] [Full Text] [Related]
5. Better actual 10-year renal transplant outcomes of 80% reduced cyclosporine exposure with sirolimus base therapy compared with full cyclosporine exposure without or with concomittant sirolimus treatment. Pliszczynski J; Kahan BD Transplant Proc; 2011 Dec; 43(10):3657-68. PubMed ID: 22172822 [TBL] [Abstract][Full Text] [Related]
6. Effect of sirolimus in combination with low-dose cyclosporine and steroids on acute renal allograft rejection. Tsai MK; Chueh SC; Hu RH; Lee PH J Formos Med Assoc; 2003 Feb; 102(2):91-6. PubMed ID: 12709737 [TBL] [Abstract][Full Text] [Related]
7. The role of Certican (everolimus, rad) in the many pathways of chronic rejection. Nashan B Transplant Proc; 2001; 33(7-8):3215-20. PubMed ID: 11750380 [No Abstract] [Full Text] [Related]
8. Tacrolimus rescue therapy for renal transplant rejection. Jordan ML; Shapiro R; Naraghi R; Smith D; Vivas C; Gritsch HA; Scantlebury V; Randhawa P; Demetris AJ; Fung JJ; Starzl TE Transplant Proc; 1996 Aug; 28(4):2119-20. PubMed ID: 8769174 [No Abstract] [Full Text] [Related]
9. Rapamycin in a porcine renal transplant model. Almond PS; Moss A; Nakhleh R; Melin M; Chen S; Salazar A; Shirabe K; Matas A Transplant Proc; 1993 Feb; 25(1 Pt 1):716. PubMed ID: 8438452 [No Abstract] [Full Text] [Related]
10. Sirolimus antirejection therapy for renal transplantation with cyclosporine-based immunosuppression: case reports. Tsai MK; Hu RH; Lee PH Transplant Proc; 2003 Feb; 35(1):219-20. PubMed ID: 12591371 [No Abstract] [Full Text] [Related]
11. Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine. Ponticelli C; Tarantino A; Aroldi A; Sparacino V; Stefoni S; Citterio F; Duca L; Scolari MP; Calabrese S; Altieri P; Civati G; Cesana B Transplant Proc; 2003 May; 35(3 Suppl):62S-63S. PubMed ID: 12742469 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and safety of conversion therapy with the combination of sirolimus with low dose cyclosporine in renal transplantation recipients: a five-year clinical observation]. Zhu L; Ding T; Wang XX; Lin ZB; Chen G Zhonghua Yi Xue Za Zhi; 2016 May; 96(20):1556-61. PubMed ID: 27266681 [TBL] [Abstract][Full Text] [Related]